Quality by design to define critical process parameters for mesenchymal stem cell expansion

Area of Science:

• Regenerative Medicine
• Biotechnology
• Pharmaceutical Manufacturing

Background:

• Stem cell therapies offer potential treatments for severe diseases.
• Reproducible manufacturing of high-quality cell products is essential for commercialization.
• Current challenges include defining science-based quality standards for regulatory approval.

Purpose of the Study:

• To apply a Quality by Design (QbD) approach to Mesenchymal Stem Cell (MSC) manufacturing.
• To identify Critical Process Parameters (CPPs) impacting Critical Quality Attributes (CQAs) in MSC production.
• To promote standardization and facilitate Good Manufacturing Practice (cGMP) compliance.

Main Methods:

• Bibliographic analysis of published studies on MSC manufacturing.
• Application of QbD principles to assess process parameters.
• Identification and classification of CPPs during cell extraction and amplification stages.

Main Results:

• Key process parameters influencing MSC Critical Quality Attributes were identified.
• Critical Process Parameters (CPPs) were classified for cell extraction and amplification.
• The study provides a framework for science-based quality standards in MSC manufacturing.

Conclusions:

• A QbD approach can enhance the robustness and reproducibility of MSC manufacturing.
• Identifying CPPs is vital for reducing product rejection and ensuring regulatory compliance.
• This work contributes to bridging the gap towards compliant cGMP manufacturing of stem cell therapeutics.